Data as of Dec 24
| 0.00 / 0.00%|
The 6 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 45.50, with a high estimate of 60.30 and a low estimate of 15.12. The median estimate represents a +154.87% increase from the last price of 17.85.
The current consensus among 7 polled investment analysts is to Buy stock in Mesoblast Ltd. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.